Abstract

Scalar relativistic density functional theory (DFT) has been used to explore the spectroscopic and redox properties of Ruthenium-type photovoltaic sensitizers, trans-[Ru((R)L)(NCS)(2)] ((R)L = 4,4'''-di-R-4',4''-bis(carboxylic acid)-2,2' : 6',2'' : 6'',2'''-quaterpyridine, R = H (1), Me (2), (t)Bu (3) and COOH (4); (R)L = 4,4'''-di-R-4',4''-bis(carboxylic acid)-cycloquaterpyridine, R = COOH (5)). The geometries of the molecular ground, univalent cationic and triplet excited states of 1-5 were optimized. In complexes 1-4, the quaterpyridine ligand retains its planarity in the molecular, cationic and excited states, although the C≡N-Ru angle representing the SCN → Ru coordination approaches 180° in the univalent cationic and triplet excited states. The theoretically designed complex 5 displays a curved cycloquaterpyridine ligand with significantly distorted SCN → Ru coordination. The electron spin density distributions reveal that one electron is removed from the Ru/NCS moieties upon oxidation and the triplet excited state is due to the Ru/NCS → polypyridine charge transfer (MLCT/L'LCT). The experimental absorption spectra were well reproduced by the time-dependent DFT calculations. In the visible region, two MLCT/L'LCT absorption bands were calculated to be at 652 and 506 nm for 3, agreeing with experimental values of 637 and 515 nm, respectively. The replacement of the R- group with -COOH stabilizes the lower-energy unoccupied orbitals of π* character in the quaterpyridine ligand in 4. This results in a large red shift for these two MLCT/L'LCT bands. In contrast, the lower-energy MLCT/L'LCT peak of 5 nearly disappears due to the introduction of cycloquaterpyridine ligand. The higher energy bands in 5 however become broader and more intense. As far as absorption in the visible region is concerned, the theoretically designed 5 may be a very promising sensitizer for DSSC. In addition, the redox potentials of 1-5 were calculated and discussed, in conjunction with photosensitizers such as cis-[Ru(L(1))(2)(X)(2)] (L(1) = 4,4'-bis(carboxylic acid)-2,2'-bipyridine; X = NCS(-) (6), Cl(-) (7) and CN(-) (8)), cis-[Ru(L(1)')(2)(NCS)(2)] (L(1)' = 4,7-bis(carboxylic acid)-1,10-phenanthroline, 9), [NH(4)][Ru(L(2))(NCS)(3)] (L(2) = 4,4',4''-tris(carboxylic acid)-2,2' : 6',2''-terpyridine, 10) and [Ru(L(2))(NCS)(3)](-) (11).

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.